Nucleic Acid Vaccine-Induced Immune Responses Require CD28 Costimulation and Are Regulated by CTLA4
Open Access
- 15 March 1998
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 160 (6) , 2706-2714
- https://doi.org/10.4049/jimmunol.160.6.2706
Abstract
Immunization with plasmids expressing specific genes (DNA or nucleic acid vaccination (NAV)) elicits robust humoral and cell-mediated immune responses. The mechanisms involved in T cell activation by NAV are incompletely characterized. We have examined the costimulatory requirements of NAV. CD28-deficient mice did not mount Ab or CTL responses following i.m. immunization with eukaryotic expression plasmids encoding the bacterial gene β-galactosidase (βgal). Because these mice retained their ability to up-regulate the CTLA4 receptor (a negative regulator of T cell activation), we examined CTLA4’s role in the response of wild-type BALB/c mice to NAV. Intact anti-CTLA4 mAb but not Fab fragments suppressed the primary humoral response to pCIA/βgal without affecting recall responses, indicating CTLA4 activation inhibited Ab production but not T cell priming. Blockade of the ligands for CD28 and CTLA4, CD80 (B7-1) and CD86 (B7-2), revealed distinct and nonoverlapping function. Blockade of CD80 at initial immunization completely abrogated primary and secondary Ab responses, whereas blockade of CD86 suppressed primary but not secondary responses. Simultaneous blockade of CD80 + CD86 was less effective at suppressing Ab responses than either alone. Enhancement of costimulation via coinjection of B7-expressing plasmids augmented CTL responses but not Ab responses, and without evidence of Th1 to Th2 skewing. These findings suggest complex and distinct roles for CD28, CTLA4, CD80, and CD86 in T cell costimulation following nucleic acid vaccination.Keywords
This publication has 65 references indexed in Scilit:
- B7-1 and B7-2 Have Overlapping, Critical Roles in Immunoglobulin Class Switching and Germinal Center FormationImmunity, 1997
- Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNAGene Therapy, 1997
- Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cellsImmunology, 1996
- Overview of DNA VaccinesAnnals of the New York Academy of Sciences, 1995
- DNA-Mediated Immunization and the Energetic Immune Response to Hepatitis B Surface AntigenClinical Immunology and Immunopathology, 1995
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994
- The B7 and CD28 receptor familiesImmunology Today, 1994
- The immunobiology of muscleImmunology Today, 1994
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992